The USFDA approves Xolair for severe food allergies, reducing anaphylaxis risk in children. This groundbreaking advancement in allergy treatment brings hope to millions.
Pharmaceutical company Haleon recalls Robitussin cough medicines due to microbial contamination, posing potential health risks, especially for immunocompromised individuals.
Aside from the previous COVID-19 virus, experts are growing concerned about the spike prion regions on the spike proteins. These could potentially trigger prion-linked diseases in humans.
Ireland secures access to Libmeldy, the world's priciest drug for Metachromatic Leukodystrophy, benefiting children. Beneluxa initiative's negotiations with Orchard Therapeutics led to an undisclosed lower cost.